U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07684573) titled 'Scar Gel Product Family Clinical Investigation' on June 29.
Brief Summary: The purpose of this PMCF investigation is to determine whether there are differences between the two formulations (Dermatix and Dermatix Ultra) in improving keloid and hypertrophic scars clinical symptoms and in the overall scar perception (including scar appearance and treatment perception).
This PMCF investigation has been designed to address the conclusions of the latest CER [PDPROJ-4-CE-R] and the objectives. It has been chosen as an appropriate activity as it enables the collection of device-specific data on both device formulations and on the entire int...